CD274 and non-small cell lung carcinoma: and Hisao Imai et al., high BMI was found to be a protective factor for better ICIs response in first‐line treatment with high PD‐L1 expression, as well as second‐line treatment regardless of PD‐L1 expression in NSCLC.7, 8, 18